Monday, August 20, 2018

DAILY GASP 08.20.18

UPDATE: EpiPen Crisis may have an answer...  

Teva Pharmaceuticals USA, is offering an alternative to the Mylan epinephrine auto-injecto EpiPen. The FDA has approved, for market a direct generic competitor of the Epi-Pen device. There is a version for pediatric patients, a generic EpiPen Jr. In an emergency situation an auto-inject device is use to deliver a single dose of epinephrine, directly into the suffer's thigh. This attempt to stop the deadly allergic - anaphylactic shock - reaction, if vital to the suffer's survival. Without it they die.

READ MORE: Years after Mylan’s epic EpiPen price hikes, it finally gets a generic rival